Breath Of Fresh Air

Transforming Lung Health With Cross Cancer Knowledge

How might we take lessons learned in cancer fields facing similar early detection challenges and gain fresh perspectives from those outside the medical field to shape a more hopeful future for lung cancer patients?

In partnership with AstraZeneca, the UNSW Founders brings you this 1-day rapid problem-solving event invites big vision thinkers to come together to create innovative and sustainable solutions to improve the outcome for people living with Lung Cancer.

Event details

Lung cancer remains Australia’s leading cause of cancer deaths, with a 5-year survival rate only 20.2%comparatively, the 5-year survival rate for breast cancer & prostate cancer are 91.5% and 95.5% respectively^.

New and innovative solutions are needed to diagnose patients earlier, enhance patient outcomes and reduce mortality rates.

Lessons learned from successfully managing other cancers with similar challenges can serve as a valuable foundation for developing strategies for lung cancer.

Early screening for lung cancer is vital as it enables the detection of the disease at its most treatable stages, improving the chances of successful treatment.

By leveraging collective knowledge, expertise, and creativity, this challenge has the potential to inspire ground-breaking solutions that revolutionize lung cancer care and save lives.

With a share of $7000 cash prizes up for grabs (provided by UNSW), challenge participants will tackle the problem challenge:

How might we take lessons learned in cancer fields facing similar early detection challenges, and gain fresh perspectives from those outside the medical field, to shape a more hopeful future for lung cancer patients?

Challenge support: Speakers, Mentors and Judges

Teams and prize winners

Team 6 - FIRST PLACE PRIZE $4000

Team Lung Story Short - RUNNER UP PRIZE $2000

Team Lung Story Short- PEOPLE’S CHOICE AWARD $1000

Team Tranqui Lungs

Team BreatheMate

Team UrLung

Team 5

Team CAN Screen

AstraZeneca Pty. Ltd. ABN 54 009 682 311. 66 Talavera Road, Macquarie Park, NSW 2113.
www.astrazeneca.com.au. AU-17549 Date of Preparation: February 2024